STRS Ohio’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-47,000
Closed -$1.39M 2061
2023
Q4
$1.39M Buy
47,000
+18,000
+62% +$358K 0.01% 765
2023
Q3
$460K Sell
29,000
-47,600
-62% -$792K ﹤0.01% 1308
2023
Q2
$1.45M Sell
76,600
-7,800
-9% -$92.1K 0.01% 772
2023
Q1
$324K Hold
84,400
﹤0.01% 1481
2022
Q4
$418K Sell
84,400
-47,600
-36% -$258K ﹤0.01% 1389
2022
Q3
$630K Hold
132,000
﹤0.01% 1185
2022
Q2
$594K Buy
132,000
+4,000
+3% +$17.4K ﹤0.01% 1267
2022
Q1
$609K Hold
128,000
﹤0.01% 1355
2021
Q4
$949K Buy
128,000
+4,100
+3% +$25.5K ﹤0.01% 1149
2021
Q3
$702K Sell
123,900
-5,100
-4% -$29.5K ﹤0.01% 1354
2021
Q2
$850K Buy
+129,000
New +$900K ﹤0.01% 1273
2016
Q4
Sell
-24,100
Closed -$64K 2002
2016
Q3
$64K Sell
24,100
-900
-4% -$2.62K ﹤0.01% 1732
2016
Q2
$77K Hold
25,000
﹤0.01% 1715
2016
Q1
$213K Hold
25,000
﹤0.01% 1498
2015
Q4
$339K Buy
25,000
+900
+4% +$11.1K ﹤0.01% 1402
2015
Q3
$231K Buy
+24,100
New +$352K ﹤0.01% 1500

Other funds holding IMGN

STRS Ohio's IMGN Position: Q1 2024 in Review

STRS Ohio sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 47,000 shares — an estimated $1.39M sold.

STRS Ohio first reported a position in IMGN in Q3 2015 and held it in 16 quarters. The position peaked at $1.45M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • STRS Ohio reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • STRS Ohio sold 47,000 Immunogen Inc shares in Q1 2024, an estimated $1.39M.
  • STRS Ohio first reported a position in Immunogen Inc in Q3 2015 and held it in 16 quarters.
  • STRS Ohio's Immunogen Inc position peaked at $1.45M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on STRS Ohio's 13F filing for Q1 2024, filed 13 May 2024.